Filter
3176
Filtered Results: 3176
Text search:
International
Association
of
National
Public
Health
Institutes
Featured
Recommendations
249
New Publications
818
Language
Document type
No document type
1906
Studies & Reports
596
Guidelines
309
Manuals
157
Strategic & Response Plan
100
Training Material
55
Fact sheets
24
Situation Updates
16
Resource Platforms
7
Brochures
3
App
1
Infographics
1
Online Courses
1
Countries / Regions
India
131
Global
118
Kenya
98
Ethiopia
82
Western and Central Europe
80
Liberia
58
Nigeria
58
Uganda
58
Rwanda
58
Nepal
56
South Africa
52
Africa
50
Myanmar / Burma
49
Ghana
47
Malawi
44
Latin America and the Carribbean
42
Zambia
41
Tanzania
41
Sierra Leone
40
Bangladesh
40
Ukraine
38
Philippines
35
Cambodia
33
Indonesia
27
Eastern Europe
27
Congo, Democratic Republic of
26
Syria
26
Mozambique
26
Asia
26
Namibia
24
Russia
22
Germany
21
Zimbabwe
20
Burkina Faso
19
South–East Asia Region
19
Guinea
17
Senegal
17
Cameroon
14
Thailand
13
Lesotho
13
East and Southern Africa
13
Brazil
12
Pakistan
11
South Sudan
11
Botswana
11
West and Central Africa
11
USA
10
Haiti
10
Benin
10
Vietnam
10
China
9
Lebanon
8
Turkey
8
Colombia
8
Mali
7
Jordan
7
Afghanistan
7
Peru
7
Eswatini/ Swaziland
7
Western Pacific Region
7
Eastern Europe and Central Asia
7
Albania
7
North Macedonia
6
Venezuela
6
Somalia
5
Iraq
5
Central African Republic
5
Sri Lanka
5
Yemen
5
Middle East and North Africa
5
Laos
5
Sudan
4
Chile
4
Tajikistan
4
Moldova
4
Iran
4
Kyrgyzstan
4
Portugal
4
Egypt
3
Papua New Guinea
3
El Salvador
3
Angola
3
Mexico
3
Paraguay
3
Poland
3
Romania
3
Turkmenistan
3
Japan
3
Spain
3
Niger
2
Chad
2
Gambia
2
Malaysia
2
Serbia
2
Hungary
2
Croatia
2
Honduras
2
Ecuador
2
Guatemala
2
Bhutan
2
Palestine
2
Southern Africa
2
Canada
2
Estonia
2
Lithuania
2
United Kingdom
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Togo
1
Singapore
1
Vanuatu
1
Argentina
1
Burundi
1
Bolivia
1
Madagascar
1
Nicaragua
1
Other region
1
Solomon Islands
1
North Korea
1
Italy
1
Armenia
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Slovakia
1
Uzbekistan
1
Kazakhstan
1
Georgia
1
North America
1
Jamaica
1
Denmark
1
France
1
Mauritius
1
Norway
1
Azerbaijan
1
Belarus
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1118
Clinical Guidelines
220
Public Health
202
Women & Child Health
150
Key Resources
135
Capacity Building
32
Pharmacy & Technologies
28
Annual Report MEDBOX
1
General Guidelines
1
Toolboxes
Mental Health
366
HIV
246
COVID-19
174
TB
172
Planetary Health
172
Disability
153
AMR
107
Rapid Response
89
NCDs
83
Global Health Education
78
Caregiver
72
NTDs
71
Ebola
64
Conflict
57
Refugee
54
Pharmacy
44
Natural Hazards
32
Health Financing Toolbox
30
Zika
23
Specific Hazards
17
Polio
12
Social Ethics
12
Cholera
7
Typhoon
2
This guidance document has been produced by WHO to assist blood services in the development of national plans to respond to any emerging infectious threats to the sufficiency or safety ... the blood supply, whether from an existing infectious agent that is changing in incidence and spread, or from a newly identified infectious agent. It is intended that this document be followed to guide the national blood service through the process of planning how to respond in a timely, controlled and appropriate way to any specific infectious threat that may subsequently emerge. It is acknowledged that it is not only the blood supply that may be affected by such emerging infectious threats; in those countries undertaking transplantation, the supply of cell, tissues and organs may also be threatened. Increasingly, blood services are taking overall national responsibility for transplantation in their capacity as the organization responsible for the collection, processing, storage and supply of cells, tissues and organs. This approach is both sensible and appropriate, as the overall donor selection and screening processes are the same or very similar. This guidance document can therefore also be used to assist those bodies responsible for the provision of cells, tissues and organs to prepare for an emerging infectious threat.
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in...
This document shall serve as the most comprehensive set of guidelines on the safe management of waste generated from heath care activities in the country. It incorporates the requirements ... all Philippine laws and regulations governing HCWM and is designed for the use of individuals, public and private establishments, and other entities involved in segregation, collection, handling, storage, treatment,and disposal of waste generated from heath care activities.
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use ... COVID-19 simulation exercises to test deployment strategies;
the indemnity agreement and no-fault compensation programme for vaccines secured through the COVAX Facility in the Advance Market Commitment (AMC) eligible economies;
the availability and use of the WHO-UNICEF COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool;
the COVAX Facility’s humanitarian buffer that enables allocation of vaccine to cover high-risk populations in humanitarian settings;
recommendations for vaccination of pregnant and lactating women;
supplementary information on infection prevention and control (IPC) measures to be used to deliver COVID-19 vaccines safely;
the WHO licensed COVID-19 vaccines product-specific information;
use of geospatial data and digital micro plans for equitable access and delivery of COVID-19 vaccines;
lessons learned from the development of NDVPs and early experiences in COVID-19 vaccine deployment in countries; and
updated additional resources at the end of each chapter.
The Government of the Republic of Zambia has placed priority on ensuring that Zambians are healthy and productive as a catalyst to the attainment of...
his Inter Action Review report for the COVID-19 outbreak in Mauritius documents and assesses the country’s capacity to respond to the outbreak and identifies the best practices, strengths, gaps and challenges of the ... response. Areas requiring improvements or sustained actions have been identified across the 9 strategic pillars of World Health Organization (WHO)’s COVID-19 Strategic Preparedness and Response Plan and an additional pillar for the country’s response beyond health. On an overall, the review aims to enhance and sustain the national response with a particular focus on strengthening the health systems.
This CPD Policy relates to all health professionals in the four Health Professional Councils in Rwanda namely; RMDC, NCNM, RAHPC, and RPC. The policy requires all ... professionals to participate in the CPD Programs. The purpose of this CPD Policy is to support the professionals in the respective councils to develop a culture of continuing learning, acquire new knowledge and skills, and ensure efficient regulation and appropriate delivery of healthcare services to the community.
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, pu...
Biodiversity and healthy natural ecosystems, including protected areas in and around cities, provide ecosystem benefits and services that support human health, including reducing flood risk, filtering air pollutants, and providing a reliable supply ...
There is no guarantee that a successful pilot program introducing a reproductive health innovation can also be expanded successfully to the national or regional level, because the scaling-up process...
HelpAge International is a global network of organisations promoting the right of all older people to lead dignified, healthy and secure lives. Con...
The WHO European Office for the Prevention and Control of Noncommunicable Diseases organized an expert meeting on monitoring of digital marketing of...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically ...
This guideline provides updated, evidence-informed guidance on the percentage of total fat in the diet to reduce the risk of unhealthy weight gain.
This guideline is intended for a wide audience ...
The WHO Toolkit for the care and support of people affected by complications associated with Zika virus has been developed to serve as a model guide, with the goal of enhancing country preparedness...
interim Guidance 1 December 2020. Updated version
This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, ... health and infection prevention and control professionals, health care managers and health workers.
The Annex provides advice on how to manufacture non-medical masks. It is intended for those making non-medical masks at home and for mask manufacturers
Summary Report on the Comprehensive Study
This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The co...
Ukrainian decentralization reform has increased and democratized local government responsibility for health care at the level of local government closest to communities and has increased regional an...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as ... 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly replacing Delta worldwide – was considered Omicron has a substantial growth advantage, higher secondary attack rates and a higher observed reproduction number than Delta.
There is now significant evidence that immune evasion contributes to the rapid spread of Omicron. Other factors may be a shorter
serial interval (by about 0.8 to 1.2 days compared to Delta) and potential increased intrinsic transmission fitness . There is
growing evidence that with Omicron, there is lower vaccine effectiveness (VE) against infection and symptomatic disease soon after vaccination compared to Delta. There is also evidence of accelerated waning of VE over time of the primary series against infection and symptomatic disease for the studied vaccines. Further studies are required to better understand the drivers of transmission and declining incidence in various settings. These factors include the intrinsic transmission fitness properties of the virus, degree of immune evasion, vaccination coverage and level of vaccine-derived and post-infection immunity, levels of social mixing and degree of application of public health and social measures (PHSM).
